Morgan Stanley’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.1M Sell
1,002,468
-865
-0.1% -$70.9K ﹤0.01% 1696
2025
Q4
$78.4M Sell
1,003,333
-129,484
-11% -$10.5M ﹤0.01% 1665
2025
Q3
$96.2M Buy
1,132,817
+84,912
+8% +$6.8M 0.01% 1436
2025
Q2
$81.9M Buy
1,047,905
+52,449
+5% +$3.87M 0.01% 1492
2025
Q1
$72M Sell
995,456
-41,728
-4% -$3.5M 0.01% 1492
2024
Q4
$92M Sell
1,037,184
-167,614
-14% -$14.9M 0.01% 1319
2024
Q3
$102M Buy
1,204,798
+5,277
+0.4% +$468K 0.01% 1221
2024
Q2
$111M Buy
1,199,521
+59,553
+5% +$6.02M 0.01% 1111
2024
Q1
$129M Sell
1,139,968
-1,093,522
-49% -$109M 0.01% 1025
2023
Q4
$208M Buy
2,233,490
+1,253,914
+128% +$110M 0.01% 1126
2023
Q3
$89.9M Buy
979,576
+36,680
+4% +$3.94M 0.01% 1128
2023
Q2
$114M Buy
942,896
+152,918
+19% +$16.5M 0.01% 1008
2023
Q1
$77.3M Buy
789,978
+87,808
+13% +$8.38M 0.01% 1214
2022
Q4
$56.9M Buy
702,170
+571,710
+438% +$48M 0.01% 1393
2022
Q3
$9.92M Sell
130,460
-36,516
-22% -$3.51M ﹤0.01% 2994
2022
Q2
$18.2M Buy
166,976
+39,045
+31% +$4.15M ﹤0.01% 2396
2022
Q1
$12.7M Sell
127,931
-52,472
-29% -$5M ﹤0.01% 2617
2021
Q4
$17.2M Buy
180,403
+63,372
+54% +$6.35M ﹤0.01% 2316
2021
Q3
$12.9M Buy
117,031
+17,404
+17% +$1.98M ﹤0.01% 2590
2021
Q2
$11.5M Buy
99,627
+11,266
+13% +$1.29M ﹤0.01% 2821
2021
Q1
$9.2M Buy
88,361
+42,469
+93% +$5.28M ﹤0.01% 2740
2020
Q4
$5.52M Buy
45,892
+9,565
+26% +$965K ﹤0.01% 3156
2020
Q3
$3.15M Sell
36,327
-58,381
-62% -$5.02M ﹤0.01% 3192
2020
Q2
$7.67M Sell
94,708
-53,610
-36% -$3.91M ﹤0.01% 2223
2020
Q1
$10.2M Buy
148,318
+66,390
+81% +$7M ﹤0.01% 1750
2019
Q4
$9.37M Sell
81,928
-105,232
-56% -$13.1M ﹤0.01% 2499
2019
Q3
$24.4M Buy
187,160
+124,175
+197% +$16.2M 0.01% 1340
2019
Q2
$7.72M Buy
62,985
+12,283
+24% +$1.41M ﹤0.01% 2443
2019
Q1
$5.33M Sell
50,702
-4,102
-7% -$441K ﹤0.01% 2643
2018
Q4
$5.61M Sell
54,804
-41,847
-43% -$4.65M ﹤0.01% 2765
2018
Q3
$11.5M Buy
96,651
+43,074
+80% +$4.87M ﹤0.01% 2270
2018
Q2
$5.14M Sell
53,577
-20,289
-27% -$1.88M ﹤0.01% 3107
2018
Q1
$6.01M Buy
73,866
+6,221
+9% +$482K ﹤0.01% 2835
2017
Q4
$4.88M Sell
67,645
-17,306
-20% -$1.18M ﹤0.01% 3130
2017
Q3
$5.22M Buy
84,951
+5,340
+7% +$325K ﹤0.01% 2921
2017
Q2
$4.81M Buy
79,611
+20,991
+36% +$1.34M ﹤0.01% 2882
2017
Q1
$3.83M Sell
58,620
-5,908
-9% -$419K ﹤0.01% 3153
2016
Q4
$4.53M Sell
64,528
-28,738
-31% -$1.83M ﹤0.01% 3103
2016
Q3
$5.85M Buy
93,266
+50,968
+120% +$3.14M ﹤0.01% 2518
2016
Q2
$2.55M Buy
42,298
+921
+2% +$50.5K ﹤0.01% 3225
2016
Q1
$2.06M Buy
41,377
+31,003
+299% +$1.54M ﹤0.01% 3329
2015
Q4
$557K Sell
10,374
-2,620
-20% -$131K ﹤0.01% 4471
2015
Q3
$583K Sell
12,994
-13,668
-51% -$681K ﹤0.01% 4505
2015
Q2
$1.46M Buy
26,662
+10,321
+63% +$511K ﹤0.01% 3912
2015
Q1
$777K Sell
16,341
-23,144
-59% -$984K ﹤0.01% 4321
2014
Q4
$1.66M Sell
39,485
-408
-1% -$16.1K ﹤0.01% 3724
2014
Q3
$1.41M Sell
39,893
-3,156
-7% -$112K ﹤0.01% 3737
2014
Q2
$1.47M Buy
43,049
+35,775
+492% +$1.15M ﹤0.01% 3732
2014
Q1
$252K Sell
7,274
-17,265
-70% -$573K ﹤0.01% 4992
2013
Q4
$865K Buy
24,539
+5,858
+31% +$192K ﹤0.01% 4041
2013
Q3
$581K Sell
18,681
-10,670
-36% -$315K ﹤0.01% 4231
2013
Q2
$812K Buy
+29,351
New +$776K ﹤0.01% 3888

Other funds holding USPH

Morgan Stanley's USPH Position: Q1 2026 in Review

Morgan Stanley reduced its US Physical Therapy (USPH) stake by 0.09% in Q1 2026, selling an estimated $70.9K and leaving 1,002,468 shares worth $75.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Morgan Stanley first reported a position in USPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $208M in Q4 2023. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.

  • Morgan Stanley held 1,002,468 shares of US Physical Therapy worth $75.1M as of Q1 2026.
  • Morgan Stanley sold 865 US Physical Therapy shares in Q1 2026, an estimated $70.9K.
  • US Physical Therapy made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #1696 holding.
  • Morgan Stanley first reported a position in US Physical Therapy in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's US Physical Therapy position peaked at $208M in Q4 2023.
  • 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.